GlaxoSmithKline PLC
21 February 2003
GLAXOSMITHKLINE plc - Notification of Major Interests in Shares
GlaxoSmithKline plc (the Company) yesterday received notification from Barclays
in compliance with Part VI of the Companies Act 1985 (as amended), that on 17
February 2003 it had the following interests in the Company's Ordinary Shares of
25 pence:
Registered Holder Current shareholding
Barclays Capital Securities Limited 1,288,771
Barclays Private Bank and Trust Limited 732,755
Barclays Nikko Global Investors Limited 2,102,818
Barclays Private Bank Limited 3,082,350
Woolwich Pension Fund Trust Company Limited 337,150
Barclays Global Fund Advisors 1,806,595
Barclays Life Assurance Company Limited 10,505,429
Barclays Global Investors Japan Trust & Banking Co Limited 6,205,095
Barclays Global Investors Australia Limited 1,876,447
Barclays Global Investors, N.A. 62,414,400
Woolwich Life Limited 995,000
Barclays Global Investors Japan 112,020
Barclays Global Investors Limited 88,449,756
Barclays Bank Trust Company Limited 1,071,469
TOTAL 180,980,055
This total holding represents 3.00 per cent of the issued share capital of the
Company.
S M Bicknell
Company Secretary
21 February 2003
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.